John Priest BBus FCPA FAICD
Executive Chairman

John is the founder of Apollo and has overseen its development and growth from inception. John has a strong commercial background with extensive experience in entering new markets, building international manufacturing capacity and developing strategies for multi-billion dollar markets dominated by large corporations. His wide-ranging experience covers industries including consumer products, technology and communications through to established infrastructure companies. He has a strong technical background in the financial disciplines, operational and marketing skills and experience in Australia and internationally. In his role as chief financial officer and director of corporate development at Coca-Cola Amatil (CCA), John oversaw the transition from a diversified consumer products/tobacco company to a global soft drinks company. He helped drive the rapid transformation of the company with the acquisition of all the Coca-Cola franchises throughout 17 countries in Eastern Europe and south-east Asia. In addition, John has Board-level experience in the operation, governance and overall development of public companies. He is a current non-executive director of Sydney Water, and a council member of the Australian Graduate School of Management, an affiliate of the Securities Institute of Australia, and a Fellow of the Australian Institute of Company Directors.

Top

Antony Basten AO FAA FTSE MBBS DPhil(Oxon) FRCP FRACP FRCPA
Non-Executive Director

Tony is a distinguished clinician scientist who holds fellowships of the Australian Academies of Science and Technical Sciences and Engineering. He is an Emeritus Professor at University of Sydney, a Senior Principal Research Fellow at the Garvan Institute and until recently was the foundation Executive Director of the Centenary Institute of Cancer Medicine & Cell Biology. He was winner of the inaugural Wellcome Australia medal for distinguished discovery and its demonstrated use, a Florey lecturer of the Royal Society, London and the chief Commonwealth advisor on the medical and scientific aspects of HIV/AIDS. He is also a director of Biotech Capital. His research spans the interface between the laboratory and the bedside. On the commercial front he has secured, together with colleagues, a number of industry grants, has experience in the running of clinical trials, and has served on the scientific advisory boards of biotechnology companies. In recognition of his contributions to medicine and health and medical research he became an Officer in the General Division Order of Australia and was elected to Fellowship of the Australian Academies of Science and Technological Sciences and Engineering and received a Centenary Medal from the Prime Minister of Australia.

Top

Jane Craig BA(Hons) MBA PhD MAICD
Chief Operating Officer

Jane has been a director of the company since its inception and has played an active role in its evolution. She has performed a range of operational and advisory roles in both large and small Australian and international public companies. Her experience includes industry and competitor reviews, core capability development, strategic planning, key problem solving skills and leadership skills. Jane has been director of the Executive MBA program at the Australian Graduate School of Management and taught strategy and strategic management at AGSM and Macquarie Graduate School of Management. She is co-author of a top selling management text and of two chapters in the Karpin report on management education. Jane has also had papers published in refereed journals relating to managing IT and competing globally. She has worked as a management consultant based in Chicago and was a national judge in the 2004 Ernst & Young Entrepreneur of the Year awards.

Top

Paul Murnane BEc MBA F Fin FAICD
Non-Executive Director

Paul was appointed a director of Apollo in April 2005. He has over 25 years experience in broking, commercial and investment banking, including Citibank, and, most recently, Goldman Sachs JBWere. He also served as Managing Director and Partner with Russell Reynolds Associates Inc, a leading global executive search firm, for 15 years. Paul is Chairman of O’Sullivan Pullini, an independent investment bank and is an adviser to a number of companies in Australia and overseas. He is also a director (and past Chairman) of Multiple Sclerosis Limited and a Director of Multiple Sclerosis Australia, a non-executive Director of The Sydney Institute and a Member of the Library Council of New South Wales.

Top